Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen DB Investment Management is a private equity and venture capital firm based in Shenzhen, China, that specializes in high-growth technology sectors. While the firm has a significant focus on semiconductors, hardware, and the Internet of Things (IoT), it also maintains a strategic presence in the life sciences and healthcare industries through its investment portfolio. The firm is led by experienced professionals from global technology and finance sectors and manages multiple funds targeting early- to middle-stage companies. Its leadership, including CEO Aiyang Wang, has been involved in the governance of notable biotechnology firms such as Origin Agritech. Shenzhen DB Investment Management aims to build an industrial ecosystem by bridging advanced hardware technologies with vertical applications, including medical devices and smart healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen DB Investment Management.